With James M. Oehler
Suggestions to amend or abolish 35 U.S.C. § 101 of the Patent Act are increasing in light of the number of software and biological patents invalidated after the Supreme Court's Alice Corp. v. CLS Bank Int'l, 134 S. Ct. 2347 (2014) and Mayo Collaborative Servs. v. Prometheus Labs., Inc., 132 S. Ct. 1289 (2012) decisions, which have been used aggressively to challenge the subject matter eligibility of patents.